GTC Biotherapeutics (fka GTCB)

[DragonBits]

I have been shocked at how little money gtc has been able to raise, either through partnerships or through private placements.

Their proposed partnership was to have brought them money in the high 7 digits (that was after the approval), even DSCO was able to raise $60 million based on not more than 19.3 million shares. Heck, even INGN raised $20.0 million from Colgate-Palmolive which purchased 3,610,760 shares of common stock at a price of $5.539. For a gene based Advexin mouthwash of all things. ??

And we all know Ingn has never gotten anything approved, and the whole gene treatment platform has yet to prove out.

I agree that the market price is no indication of value, and I agree with the board, sophisticated biotech companies and those companies investing in PIPEs are efficient at pricing. Problem with that is they have shunned this type of technology.

I have faith that GTC will do some sort of deal before they run out of cash, but I have no faith that the deal will provide them with enough cash to fund them for long.

So why has GTC had such a limited ablitiy to raise funds either through partnerships or private placements? For me that is the real problem.